Needles aren’t popular. For people with type 1 diabetes (and some with type 2 diabetes) that can be a problem, since treatment requires regular injections with insulin. Now, researchers at MIT have ...

CHICAGO--(BUSINESS WIRE)--Sol-Millennium® Medical Group, manufacturer of medical devices, including syringes for medication delivery and testing, is proud to announce the launch of InsuJet™ ...

Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows. About 21% of those on inhaled insulin had a hemoglobin A1C ...

Sol-Millennium(R) Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin administration, receiving widespread praise in Canada.

Diabetic patients are often advised insulin therapy. But taking multiple injections daily may feel like a nightmare for many. But to tackle this issue, inhaled insulin has been recently launched in ...

Imagine a device that lets people with diabetes use an app or remote control to give themselves a boost of insulin when they need it, without an injection. Researchers from ETH Zurich have developed a ...

People with diabetes have more than a few hassles, particularly at meals. They not only have to measure their blood glucose levels and inject the right amount of insulin, but carry all the relevant ...

For those of us who cringe at the sight of needles, there may someday be a less daunting alternative to getting a shot: swallowing a pill-sized device that delivers medication by painlessly pricking ...

Given the choice between tossing back a dose of medicine and pushing it through your flesh inside a cold, steel needle, most people pick the pill. Convenience, portability, and lack of skin-stabbiness ...

After obtaining a more detailed history, it was discovered that the patient had been reusing insulin needles and was not rotating sites for insulin injection. Insulin needle reuse could potentially ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...